Journal of Thoracic Oncology
07 Feb 2020
Researchers at Kanazawa University report in the Journal of Thoracic Oncology a promising novel approach for a combined treatment of the most common type of lung cancer and associated secondary cancers in the central nervous system. The approach lies in combining two cancer drugs, with one compensating for a resistance side effect of the other.
Sorry, no events coming up for this topic.
Sorry, no researchers coming up for this topic.